The University of Chicago Header Logo

Connection

Rita Nanda to Fanconi Anemia Complementation Group N Protein

Back to Details
This is a "connection" page, showing publications Rita Nanda has written about Fanconi Anemia Complementation Group N Protein.
Rita Nanda
Connection Strength
0.240
Fanconi Anemia Complementation Group N Protein
  1. TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in PALB2 or Somatic Mutations in BRCA1 or BRCA2. J Clin Oncol. 2026 Mar 10; 44(8):653-661.
    View in: PubMed
    Score: 0.240
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.